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Table of contents entry 
A new approach to the enzyme inhibitor C75 and its temporary transformation into a 
phenylseleno ether derivative is disclosed. This procedure facilitates the purification, 
manipulation and storage of C75. 
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Abstract 
C75 is a synthetic racemic α-methylene-γ-butyrolactone exhibiting antitumoural properties 
in vitro and in vivo as well as to inducing hypophagia and weight loss in rodents. These 
interesting properties are thought to be a consequence of the inhibition of the key enzymes 
FAS and CPT1 in lipid metabolism. The need for larger amounts of this compound for 
biological evaluation prompted us to develop a convenient and reliable route to multigram 
quantities of C75 from easily available ethyl penta-3,4-dienoate 6. A recently described 
protocol for the addition of 6 to a mixture of dicyclohexylborane and nonanal followed by 
acidic treatment of the crude afforded lactone 8, as a mixture of cis and trans isomers, in 
good yield. The DBU-catalyzed isomerization of the methyl esters 9 arising from 8 gave a 
10:1 trans/cis mixture from which the trans isomer was isolated and easily transformed into 
C75. The temporary transformation of C75 into a phenylseleno ether derivative makes its 
purification, manipulation and storage easier. 
 
Introduction 
C75 is a synthetic racemic compound that acts as a potent inhibitor of mammalian type I 
fatty acid synthase (type I FAS) and, in its CoA-adducted form, inhibits carnitine 
palmitoyltransferase 1 (CPT1) activity in vivo. Over the last few years, C75 as a racemic 
mixture of its trans diastereoisomers has been used extensively in the study of fatty acid 
synthesis in metabolic disorders and cancer.1  
In the course of our ongoing search for potential new drugs against obesity and type 2 
diabetes,2 we required multigram quantities of racemic trans C75 for biological testing and 
as starting material for the preparation of new analogues. Although C75 is commercially 
available, its very high price prompted us to consider the preparation of C75 in our own 
laboratory. Surprisingly, only one procedure for its preparation has been reported by 
Kuhajda et al.3 This procedure was based on previous work4 by Carlson et al. that uses 
itaconic anhydride and p-methoxybenzyl alcohol as starting materials. Under these 
conditions C75 is obtained as a separable mixture of C75 and its cis isomer 1. In our hands, 
the laborious column chromatography process required for this separation caused significant 
isomerization of the exocyclic double bond to the endocyclic position to give inactive 
isomer 2 (Fig. 1). Herein, we proposed an alternative straightforward scalable method for 
the preparation of C75 and its separation from 1 and 2.   
O O
HO2C
C8H17 O O
HO2C
C8H17
1
O O
HO2C
C8H17
2
O O
HO2C
C8H17
3
SePh
C75
 
Figure 1. Structures of C75 and compounds 1–3. 
According to our retrosynthetic analysis of C75, the methylene group would be introduced 
in the last step from lactone trans-4 that would arise from the appropriate γ-hydroxyester 
anti-5 (Scheme 1). Taking advantage of our recent studies on the stereoselective addition of 
allenes to aldehydes,5 we envisaged that the hydroboration of ethyl penta-3,4-dienoate 6 
with dicyclohexylborane in the presence of nonanal could afford the required anti-5.6 
Herein, we report our findings in this respect.  
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Scheme 1. Retrosynthetic analysis of C75. 
Results and discussion 
The allylation and crotylation of aldehydes with 2-alkenyl boranes provide attractive and 
versatile routes to homoallylic secondary alcohols. 2-Alkenylides derived from alkali and 
alkaline earth metals generally serve as the starting points for the generation of 2-alkenyl 
boranes. However, hydroboration of allenes might be a milder alternative for obtaining such 
boron reagents. Initially, the borane adds to the sterically less hindered face of the allene to 
form a transient (Z)-2-alkenylborane. However, this kinetically formed borane reagent 
suffers fast isomerization to the thermodynamically more stable (E)-2-alkenylborane at 
room temperature. The addition of an aldehyde to this then affords a syn homoallylic 
alcohol as the major product, through a 6-membered transition state. Recently, we 
demonstrated that the hydroboration of the allene is also possible in the presence of the 
aldehyde.5b In such conditions, the (Z)-borane reagent can be trapped immediately by the 
aldehyde leading to anti adducts. Accordingly, we expected that the treatment of a mixture 
of ethyl penta-3,4-dienoate 6 and nonanal with Chx2BH would led to anti-5 by trapping the 
transient (Z)-2-alkenylborane, (Z)-7 (Scheme 2). In contrast, the hydroboration of 6 with 
dicyclohexylborane (Chx2BH) followed by the addition of nonanal would afford selectively 
the γ-hydroxyester syn-5.   
(Z)-7
C8H17CHOC8H17CHO
H
•
H
HEtOOC Chx2BH,
 
CH2Cl2,
0 ˚C→rt
EtOOC
Chx
EtOOC C8H17
OH
B
Chx EtOOC
B
Chx
Chx
BOC8H17
Chx
Chx
H
EtOOC
O
B
Chx
Chx
C8H17
H
EtOOC
EtOOC C8H17
OH
6 (E)-7
syn-5anti-5
C75
C8H17
COOEt
OH
 
Scheme 2. Mechanism of hydroboration of 6 followed by nonanal addition. 
In practice, the addition of allene 6 to a mixture of Chx2BH (1.2 equiv) and nonanal (1.2 
equiv) in CH2Cl2 gave, after work-up (triethanolamine) and chromatographic separation, a 
separable mixture of hydroxyester syn-5 and the lactone trans-8 arising from anti-5 but in a 
disappointing 6:4 ratio (Scheme 3). Apparently, the minor anti-5 isomer formed suffers a 
selective lactonization during the work-up and/or chromatographic processes to give trans-
8. The unexpected abundance of the syn isomer suggests that after the hydroboration step, 
isomerization of (Z)-7 to (E)-7 was faster than we expected. It is known that the allylic 
isomerization of the crotylboranes strongly depends on the steric hindrance of both allylic 
positions and the isomerization in (Z)-7 seems to be easier than in the more hindered 
protected allenols used in our previous work.5b When we heated the mixture in MeOH to 
reflux with acid catalysis, only 8 was obtained in 68% overall yield as a 6:4 cis/trans 
mixture that was difficult to separate. As expected, isolated syn-5 afforded only cis-8 under 
acidic conditions. 
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Scheme 3. One-pot synthesis of lactones 8 
In an effort to improve the proportion of trans-8, the experimental conditions were revised. 
Lower temperatures (0 ºC or –20 ºC) slowed down Z/E isomerization of 7 but hydroboration 
was incomplete and yields diminished. Neither changing the solvent (THF, Et2O), or work-
up (triethanolamine or H2O2) nor a fine tuning of the allene/aldehyde/Chx2BH ratio were 
satisfactory. Consequently, we considered the use of more hindered hydroborating agents. 
Both (–)-Ipc2BH7 (Ipc = isopinocampheyl), and disiamylborane8 were tested since these 
bulky reagents are less prone to undergo boratropic isomerization providing a greater 
opportunity for trapping the Z reagent. Furthermore, by using an enantiopure boron reagent, 
the reaction could, in principle, become enantioselective. Unfortunately, neither of the 
reagents improved the trans-8/syn-5 ratio significantly but also led to lower yields (40-
45%). In addition, the GC analysis of the trans-8 obtained with (–)-Ipc2BH revealed low 
enantioselectivities (55:44 ratio).  
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1 (Chx)2BH CH2Cl2 0 ºC rt
N(CH2CH2OH)3
71 60:40
2 (Chx)2BH CH2Cl2 –20 ºC rt 54 45:55
3 (Chx)2BH THF 0 ºC rt 50 65:35
4 (Chx)2BH Et2O 0 ºC rt 42 65:35
5b (Chx)2BH CH2Cl2 0 ºC rt 68 58:42
a A minor amount (<4%) of cis-8 was detected in all the cases.
b Oxidative work-up (H2O2, pH 7) was used instead of triethanolamine.
c A 1.4:1.2:1 (Chx)2BH/nonanal/6 ratio was used.
6c (Chx)2BH CH2Cl2 0 ºC rt 60 60:40
7 (–)-Ipc2BH CH2Cl2 0 ºC rt 45 62:38
8 disiamyl
borane
THF-CH2Cl2 0 ºC rt 40 45:55
(1.2 equiv.)
 
Table 1. Hydroboration-addition of 6 to nonanal by "one-pot" protocol. 
On the other hand, when we performed the alternative stepwise process for comparative 
purposes, i.e. hydroboration of 6 (CH2Cl2 or THF) with (Chx)2BH (1.2 equiv.) followed by 
addition of nonanal at –78 ºC, only complex reaction mixtures containing compounds 5 or 8 
in low yield (<15%) were obtained. These results are in sharp contrast with previous ones 
both from our laboratory5 and others9 in which terminal allenes undergo addition to 
aldehydes in good yields under similar conditions. Our results suggest that, although the 
starting allene readily disappeared in the hydroboration step (as observed by TLC), the 
resulting alkenylborane decomposed at 0 ºC giving a mixture of by-products.10  
Consequently, we turned our attention to the former one-pot hydroboration with Chx2BH 
(Scheme 3). Having in hand the mixture of lactones 8, the oxidation11 of the vinyl group 
was performed with NaIO4/RuCl3 to afford almost quantitatively a mixture of acids 4. 
Gratifyingly the transformation of 4 into methyl esters 9 allowed us to improve the 
diastereomeric ratio to 10:1 trans/cis by heating the mixture with DBU in dry toluene. The 
compound trans-9 was then easily isolated chromatographically and then hydrolyzed to 
obtain >95% stereopure trans-4.  
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Scheme 4. Preparation of trans-4 
The transformation of trans-4 into C75 was then quite straightforward (Scheme 5) and its 
methylenation by a known procedure12 completed the synthesis of C75 in a very respectable 
29% overall yield. 
Although C75 can be stored for months at 0 ºC with no loss of activity, it is prone to suffer 
facile isomerization to the more stable fully conjugated lactone 2 in solution or during 
chromatographic purifications on silica gel. We envisaged that a phenylseleno ether 
derivative should be an appropriate protecting group for such a delicate exocyclic double 
bond. After storage and/or purification, C75 could then be regenerated under mild oxidative 
conditions.13 This was confirmed by treating a sample of C75 with PhSeSePh and NaBH4 in 
EtOH to afford the seleno derivative 3 in 90% yield. It should be noted that 2 remains 
unchanged under these conditions.14 Derivative 3 could be easily purified by column 
chromatography15 and stored in a closed flask at rt for more than one year. Its treatment 
with 30% H2O2 in THF at rt then regenerated the desired C75. 
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Scheme 5. Preparation of C75 and its temporary transformation into the phenylseleno ether derivative 3. 
In conclusion, we disclose a useful new method of preparation of C75 in 29% overall yield 
based on a hydroboration ethyl penta-3,4-dienoate/addition of nonanal tandem process. The 
unexpected chemical instability of the transient 2-alkenylboranes was mitigated by a 
recently reported one-pot strategy in which the allene was hydroborated in the presence of 
the aldehyde. The formation of a considerable amount of undesired syn stereoisomer was 
overcome by transformation of the adducts into methyl esters 9. These intermediates 
allowed us minimize and remove the undesired stereoisomer. Finally, we report the 
temporary transformation of C75 into a phenylseleno derivative as a practical method for its 
purification and storage. We envisage the application of such phenylseleno derivatives to 
the preparation of new analogues of C75 in the future. 
 
Experimental 
General information 
All reactions involving moisture- or air-sensitive reagents were performed in oven-
dried glassware under N2. 1H NMR and 13C NMR spectra were recorded on Mercury 
400 or Varian Inova 300 instruments. Chemical shifts (δ) are quoted in parts per 
million and referenced to internal TMS for 1H NMR and to CDCl3 (δ	  77.0 ppm) for 13C 
NMR. Column chromatography was performed on silica gel (Merck 230-400 mesh). 
HRMS analyses were recorded on an Agilent LC/MSD-TOF mass	   spectrometer. IR 
spectra (wave numbers in cm–1) were recorded on a Nicolet 6700 FT-IR spectrometer. 
Ethyl penta-3,4-dienoate (6),16 Chx2BH,8b (–)-Ipc2BH,7 and disiamylborane8 were 
prepared according to literature procedures. Samples of cis-4-methylene-2-octyl-5-
oxotetrahydrofuran-3-carboxylic acid (1) and 4-methyl-2-octyl-5-oxo-2,5-
dihydrofuran-3-carboxylic acid (2) were obtained by Kuhajda's protocol3a for 
comparative purposes. 
cis-4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid (1). White solid. 
Mp: 81-82 °C (lit.3a 74-75.5 °C); Rf (CH2Cl2/MeOH 9:1) = 0.27; 1H NMR (300 MHz, 
CDCl3) δ 0.88 (t, J = 6.7 Hz, 3H, CH3), 1.08–1.78 (m, 14H, CH2), 4.03 (dt, J = 7.6, 2.2 
Hz, 1H, CHCOOH), 4.65 (td, J = 7.7, 5.3 Hz, 1H, CHO), 5.89 (d, J = 2.1 Hz, 1H, 
=CHH), 6.45 (d, J = 2.3 Hz, 1H, =CHH); 13C NMR: δ 14.2, 22.7, 25.7, 29.2, 29.3, 
29.5, 31.5, 31.9, 48.9, 78.3, 125.8, 133.4, 169.1, 174.2; IR (KBr): 3000-3400, 2922, 
2855, 1748, 1713, 1663. 
4-Methyl-2-octyl-5-oxo-2,5-dihydrofuran-3-carboxylic acid (2). White solid. Mp: 
113-114 °C; Rf (CH2Cl2/MeOH 8:2) = 0.22; 1H NMR (CDCl3, 400 MHz) δ 0.81 (t, J = 
6.8 Hz, 3H, CH3CH2), 1.15–1.45 (m, 12H, CH2), 1.60 (m, 2H, CH2CO), 2.24 (s, 3H, 
CH3), 5.06 (m, 1H, CHO); 13C NMR (CDCl3, 101 MHz) δ 11.2, 14.2, 22.8, 24.9, 29.3, 
29.4, 29.5, 32.0, 32.9, 81.6, 140.2, 146.8, 166.7, 172.8; IR (KBr): 3261, 2956–2854, 
1744, 1700, 1215. 
 
One-pot addition of ethyl penta-3,4-dienoate (6) to nonanal. 
a) Using dicyclohexylborane 
A solution of 6 (0.987 g, 7.79 mmol) and nonanal (1.61 mL, 9.386 mmol) in dry CH2Cl2 (3 
mL) was added via cannula to a suspension of dicyclohexylborane (1.672 g, 9.386 mmol) in 
dry CH2Cl2 (4 mL) at 0 ºC under N2. The reaction mixture was allowed to warm to room 
temperature. After 20 hours, 2.6 mL (19.55 mmol) of triethanolamine was added and the 
mixture was stirred for further 15 min. The mixture was carefully concentrated under 
vacuum and the resulting crude was purified by flash column cromatography 
(hexanes/EtOAc 9:1) affording ethyl syn-4-hydroxy-3-vinyldodecanoate syn-5 (884 mg, 
3.27 mmol, 42%) and 5-octyl-4-vinyldihydrofuran-2(3H)-one 8 (507 mg, 2.26 mmol, 29%) 
as a 20:1 mixture of trans/cis lactones. 
Ethyl syn-4-hydroxy-3-vinyldodecanoate (syn-5). Colorless oil; Rf (hexanes/EtOAc 8:2) = 
0.38; 1H NMR (300 MHz, CDCl3): δ 0.87 (t, J = 6.7 Hz, 3H, CH3), 1.19–1.49 (m, 17H, 7x 
CH2 and CH3), 2.42 (dd, J = 14.8, 8.0 Hz, 1H, CHH), 2.56 (dd, J = 14.7, 6.1 Hz, 1H, CHH), 
2.57–2.68 (m, 1H, CHCH=), 3.56 (m, 1H, CHOH), 4.11 (q, J = 7.1 Hz, 2H, CH2), 5.09–
5.19 (m, 2H, CH=CH2), 5.77 (ddd, J = 17.3, 10.4, 8.4 Hz, 1H, CH=CH2); 13C NMR (101 
MHz, CDCl3): δ 14.2, 14.4, 22.8, 26.0, 29.4, 29.7, 29.7, 32.0, 35.0, 36.6, 45.9, 60.5, 73.3, 
118.0, 136.4, 172.9; IR (film): 2924, 2854, 1781, 1167; HRMS (ESI+) calculated for 
C16H31O3 [M+H]+: 271.2268; found: 271.2260. 
trans-5-Octyl-4-vinyldihydrofuran-2(3H)-one (trans-8). Colorless oil; Rf (hexanes 
/EtOAc 9:1) = 0.28; 1H NMR (400 MHz, CDCl3): δ 0.88 (t, J = 6.9 Hz, 3H, CH3), 1.23–
1.77 (m, 14H, 7xCH2), 2.44 (dd, J = 17.2, 10.5 Hz, 1H, CHH), 2.68 (dd, J = 17.2, 8.3 Hz, 
1H, CHH), 2.73–2.82 (m, 1H, CHCH=), 4.14 (td, J = 8.3, 3.8 Hz, 1H, CHO), 5.13–5.23 (m, 
2H, CH=CH2), 5.72 (ddd, J = 17.2, 10.2, 7.9 Hz, 1H, CH=CH2); 13C NMR (101 MHz, 
CDCl3) δ 14.0, 22.6, 25.7, 29.1, 29.3, 29.3, 31.8, 33.6, 35.4, 46.3, 84.8, 117.9, 135.7, 175.7; 
IR (film): 2924, 2854, 1779, 1365, 1216; HRMS (ESI+) calculated for C14H25O2 [M+H]+: 
225.1849; found: 225.1845. 
cis-5-Octyl-4-vinyldihydrofuran-2(3H)-one (cis-8) 
A solution of syn-5 (135 mg, 0.499 mmol) in MeOH (4 mL) and 2M HCl (0.5 mL) was 
refluxed for 4 h. The solution was concentred to ~1 mL and CH2Cl2 (10 mL) was added. 
The solution was washed with sat. NaHCO3, the organic layer dried (Na2SO4) and the 
volatiles removed to give almost pure cis-8 (110 mg, 100%). Colorless oil; Rf (hexanes 
/EtOAc 9:1) = 0.25; 1H NMR (400 MHz, CDCl3): δ  0.86 (t, J = 6.8 Hz, 3H, CH3), 1.18–
1.63 (m, 14H, 7xCH2), 2.41 (dd, J = 17.3, 5.5 Hz, 1H, CHH), 2.68 (dd, J = 17.3, 8.1 Hz, 
1H, CHH), 3.09–3.18 (m, 1H, CHCH=), 4.48 (ddd, J = 9.3, 6.4, 4.4 Hz, 1H, CHO), 5.20–
5.10 (m, 2H, CH=CH2), 5.74 (ddd, J = 17.0, 10.3, 8.7 Hz, 1H, CH=CH2); 13C NMR (101 
MHz, CDCl3) δ 14.2, 22.7, 25.8, 29.3, 29.4, 29.5, 31.0, 31.9, 34.8, 43.2, 83.4, 118.1, 134.1, 
176.4; IR (film): 2923, 2854, 1775, 1365, 1160, 920; HRMS (ESI+) calculated for C14H25O2 
[M+H]+: 225.1849; found: 225.1854. 
b) Using disiamylborane 
Borane dimethyl sulfide complex (0.2 mL, 1.902 mmol) were slowly added to a solution of 
2-methyl-2-butene in dry THF (1.9 mL, 3.80 mmol) at 0 ºC under N2. The mixture was 
warmed to room temperature and stirred for 1 hour. The solution was cooled to – 78 ºC and 
a solution of allene 6 (200 mg, 1.585 mmol) and nonanal (327 µL, 1.902 mmol) in dry 
CH2Cl2 (1 mL) was added. The mixture was stirred for further 15 minutes at – 78 ºC and 20 
hours at room temperature. The reaction was quenched by addition of triethanolamine (0.5 
mL, 3.963 mmol) and the resulting solution was stirred for 1 hour. After concentration 
under reduced pressure the crude was purified by flash column chromatography 
(hexanes/EtOAc 9:1) to afford syn-5 (18%) and trans-8 (22%).  
c) Using diisopinocampheylborane 
A solution of allene 6 (200 mg, 1.585 mmol) and nonanal (327 µL, 1.902 mmol) in dry 
CH2Cl2 (2 mL) was added to a cooled suspension of diisopinocampheylborane (0.720 g, 
1.90 mmol) in dry CH2Cl2 (1 mL) at 0 ºC under N2. After 1.5 hours, the reaction was 
quenched by addition of triethanolamine (0.5 mL, 3.963 mmol) and the mixture was stirred 
at room temperature for 1 hour. The solvent was carefully removed under vacuum and the 
crude was purified by flash column chromatography (hexanes/EtOAc 95:5 and 9:1) giving 
syn-5 (28%) and trans-8 (17%). Analysis of a sample of trans-8 by GC using a chiral 
column (Supelco Alpha Dex 120, 30 m x 0.25 mm, 130 ºC, tR = 32.2 min and 32.4 min) 
showed a 55:45 enantiomeric ratio. 
 
Stepwise addition of ethyl penta-3,4-dienoate (6) to nonanal. 
A solution of 6 (0.494 g, 3.90 mmol) in dry CH2Cl2 (1 mL) was added via cannula to a 
suspension of dicyclohexylborane (0.836 g, 4.69 mmol) in dry CH2Cl2 (3 mL) at 0 ºC under 
N2. The reaction mixture was allowed to warm to room temperature. After 50 min, the 
solution was cooled again to – 78 ºC and nonanal (805 µL, 4.69 mmol) in dry CH2Cl2 (2 
mL) was added. The reaction was allowed to warm to room temperature and after 1 h 
triethanolamine (1.3 mL, 9.78 mmol) was added and the mixture was stirred for further 15 
min. The resulting mixture was carefully concentrated under vacuum to give a complex 
crude. Attempted purification by flash column chromatography (hexanes/EtOAc 95:5 and 
9:1) afforded impure fractions in which hydroxy ester 5 and lactone 8 were detected in low 
yields (<15% overall yield). 
 
Obtention of acid lactones 4 (cis/trans mixture) 
A solution of allene 6 (0.307 g, 2.430 mmol) and nonanal (0.50 mL, 2.916 mmol) in 1.5 mL 
of anhydrous CH2Cl2 was added to a suspension of dicyclohexylborane (0.519 g, 2.916 
mmol) in 1.5 mL of anhydrous CH2Cl2 under N2 at 0 ºC. The resulting mixture was stirred 
for 10 min and then for 1 h at room temperature. 3M NaOH (1 mL) and H2O2 (30% in 
water, 1 mL) were added to the reaction. After 1 h at room temperature it was diluted with 
MeOH (2 mL) and acidified with aq 2M HCl to pH ~ 1 and was then heated at reflux for 3 
hours. Water (30 mL) was added and the resulting aqueous layer was extracted with CH2Cl2 
(3x30 mL). The organic layer was dried (MgSO4) and the volatiles were removed. The 
resulting crude lactones 8 (381 mg) were used without further purification in the oxidation 
step. 
NaIO4  (2.62 g, 12.2 mmol) and RuCl3.H2O (9 mg, 0.042 mmol) were added to a stirred 
solution of lactones 8 in a 1:1:2 CCl4/CH3CN/water mixture (12 mL) at room temperature. 
After 20 h, water (40 mL) was added and the mixture was extracted with CH2Cl2 (3x40 
mL). The organic extracts were dried (MgSO4) and the volatiles were removed. The crude 
was filtered through a short pad of silica to obtain the corresponding mixture of acid 
lactones 4 (391 mg, 95%). 
 
Preparation of compounds trans-9 and cis-9 
Methyl iodide (100 µL, 1.59 mmol) was added to a mixture of acid lactones 4 (0.200 g, 
0.826 mmol) and KHCO3 (0.825 g, 8.25 mmol) in anhydrous DMF (3 mL) under N2 at 
room temperature. The mixture was stirred overnight. Water (30 mL) was added and the 
mixture was extracted with Et2O (3x40 mL). The combined organic extracts were washed 
with saturated aqueous NaHSO3 (20 mL) and brine (100 mL). The organic layer was dried 
(MgSO4) and the solvent was removed under vacuum to yield a 4:6 trans/cis mixture of 
esters 9 (0.211 g, 100%). 
1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, 120 µL, 0.80 mmol) was added to a solution of 
the mixture of esters 9 in toluene (10 mL) and the solution was heated at 100 ºC for 12 h. 
The solution was washed with 0.02M HCl (10 mL) and brine (10 mL). The organic layer 
was dried (MgSO4) and the solvent was removed under vacuum. The residue was purified 
by flash column chromatography (CH2Cl2) to afford trans-9 (167 mg, 79%) and cis-9 (17 
mg, 8%). 
Methyl trans-2-octyl-5-oxotetrahydrofuran-3-carboxylate (trans-9). Colorless oil; Rf 
(hexanes/EtOAc 7:3) = 0.46; 1H NMR (CDCl3, 300 MHz): δ 0.84–0.93 (m, 3H, CH3), 1.18–
1.59 (m, 12H, CH2), 1.64–1.84 (m, 2H, CH2), 2.77 (dd, J = 17.6, 9.5 Hz, 1H, CHHCO), 
2.92 (dd, J = 17.6, 8.7 Hz, 1H, CHHCO), 3.04 (ddd, J = 9.5, 8.7, 7.1 Hz, 1H, CHCOOMe), 
3.75 (s, 3H, CH3), 4.57 (td, J = 7.3, 5.0 Hz, 1H, CHO); 13C NMR (CDCl3, 101 MHz): δ 
14.2, 22.7, 25.2, 29.2, 29.3 29.4, 31.9, 32.3, 35.4, 45.7, 52.8, 82.0, 171.7, 174.5; IR (film), 
2953, 2926, 2855, 1790, 1739, 1201; HRMS (ESI+) calculated for C14H25O4 [M+H]+: 
257.1747; found: 257.1746. 
Methyl cis-2-octyl-5-oxotetrahydrofuran-3-carboxylate (cis-9). White solid. Mp: 43-44.5 
°C; Rf (hexanes/EtOAc, 7:3) = 0.41; 1H NMR (300 MHz, CDCl3): δ 0.84–0.93 (m, 3H, 
CH3), 1.19–1.42 (m, 12H, CH2), 1.43–1.65 (m, 2H, CH2), 2.66 (dd, J = 17.6, 8.7 Hz, 1H, 
CHHCO), 2.90	  (dd, J = 17.6, 5.7 Hz, 1H, CHHCO), 3.44 (ddd, J = 8.7, 7.4, 5.7 Hz, 1H, 
CHCOOMe), 3.75 (s, 3H, CH3), 4.62 (td, J = 7.4, 6.3 Hz, 1H, CHO); 13C NMR (101 MHz, 
CDCl3): δ 14.2, 22.8, 25.9, 29.3, 29.3, 29.5, 31.5, 31.9, 44.4, 52.4, 80.5, 170.9, 175.0; IR 
(KBr) 2914, 2851, 1775, 1726, 1241; HRMS (ESI+) calculated for C14H25O4 [M+H]+: 
257.1747; found: 257.1750. 
 
trans-2-Octyl-5-oxotetrahydrofuran-3-carboxylic acid (trans-4) 
Aqueous NaOH  (1M, 2 mL) was added to a solution of trans-9 (164 mg, 0.640 mmol) in 
THF (2 mL). The mixture was heated at 70 ºC until of the starting material disappeared (1 
h). The mixture was partitioned by adding CH2Cl2 (5 mL) and water (3 mL). The aqueous 
layer was extracted with CH2Cl2 (3 mL), decanted, acidified to pH ~1 with conc. HCl and 
heated to 70 ºC for 1h. The aqueous phase was extracted with CH2Cl2 (4x4 mL) and the 
combined organic extracts were dried (MgSO4). The solvent was removed under vacuum to 
give almost pure trans-4 as a white solid. Mp: 98-100 °C; Rf (hexanes/EtOAc/HOAc 
8:2:0.1) = 0.24; 1H NMR (CDCl3, 400 MHz): δ 0.88 (t, J = 6.7 Hz, 3H, CH3), 1.28–1.56 (m, 
12H, CH2), 1.70–1.86 (m, 2 H, CH2), 2.83 (dd, J = 9.6, 17.9 Hz, 1H, CHHCO), 2.95 (dd, J 
= 8.4, 17.9 Hz, 1H, CHHCO), 3.07–3.14 (m, 1H, CHRCOOH), 4.60–4.65 (m, 1H, CHRO); 
13C NMR (CDCl3, 101 MHz): δ 14.2, 22.8, 25.3, 29.3, 29.3, 29.5, 31.9, 32.0, 35.5, 45.3, 
82.0, 174.7, 176.7; IR (ATR): 3000–3300, 2925, 2853, 1749, 1718, 1393, 1243, 1215, 1195, 
759, 669; HRMS (ESI+) calculated for C13H22NaO4 [M+Na]+: 265.1410; found: 265.1410. 
 
trans-4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid (C75) 
A sample of trans-4 (85 mg, 0.35 mmol) was heated in a solution of MMC (magnesium 
methyl carbonate, 2M) in DMF (6 mL) at 130-135 °C under N2 for 45 h. 6M HCl (10 mL) 
and CH2Cl2 (15 mL) were added carefully. The aqueous layer was extracted with CH2Cl2 
(2×10 mL), the combined organic extracts were dried (MgSO4) and the volatiles were 
removed to afford 100 mg of residue. This crude was stirred with 1.2 mL of a freshly 
prepared stock solution (1 mL AcOH, 0.75 mL formalin, 30 mg NaAcO and 0.26 mL N-
methylaniline) for 1.45 h. To the resulting mixture, a 10:1 aq. NaCl/conc. HCl solution (5 
mL) and CH2Cl2 (12 mL) were added. The aqueous layer was extracted with CH2Cl2 
(5×10 mL). The combined organic extracts were washed with LiCl 5% (2×4 mL), HCl 
0.02 M (2×4 mL) and H2O (3×5 mL). The organic layer was stirred with sat. NaHCO3 
solution (5 mL) for 5 min and then the aqueous layer was acidified with concentrated HCl 
to pH 1-2 and was extracted with CH2Cl2 (4×10 mL). The combined organic extracts were 
washed with brine and dried (MgSO4) and the solvent was removed to give C75 as a white 
solid (54 mg, 0.21 mmol, 60%). Mp: 88-89 °C (lit.,3a 76-77 °C); Rf (CH2Cl2/MeOH 9:1) 
= 0.27; 1H NMR (400 MHz, CDCl3): δ 0.88 (t, J = 6.9 Hz, 3H, CH3), 1.20–1.53 (m, 12 
H, CH2), 1.67–1.79 (m, 2H, CH2) 3.63 (dd, J = 5.6, 2.8 Hz, 1H, CHCOOH), 4.80 (td, J 
= 7.2, 5.6 Hz, 1H, CHRO), 6.00 (d, J = 2.7 Hz, 1H, =CHH), 6.46 (d, J = 2.7 Hz, 1H, 
=CHH); 13C NMR (101 MHz, CDCl3): δ 14.2, 22.7, 24.9, 29.2, 29.3, 29.5, 31.9, 35.8, 
49.6, 79.1, 126.1, 132.5, 168.5, 174.7; IR (film): 3000–3400, 2924, 2852, 1743, 1717, 
1660, 1621, 1460; HRMS (ESI+) calculated for C14H23O4: 255.1591[M+H]+; found: 
255.1587. 
 
trans,trans-­‐2-Octyl-5-oxo-4-[(phenylselanyl)methyl]tetrahydrofuran-3-carboxylic 
acid (3). A solution of C75 (0.200 g, 0.78 mmol) in	  EtOH (3 mL) was added dropwise 
via cannula to a mixture of Ph2Se2 (0.135 g, 0.43 mmol) and NaBH4 (0.035 g, 0.94 
mmol) in EtOH (3 mL) under N2 at room temperature. The resulting yellow solution was 
stirred 3.5 h and then acidified with 2M HCl to pH = 1. Volatiles were evaporated and 
the aqueous residue was extracted with CH2Cl2 (3x8 mL). The combined organic layers 
were washed with 20% NH4Cl solution (2x5 mL) and brine (2x5 mL), dried (MgSO4) 
and the solvent was removed under vacuum. The purification of the crude by flash 
chromatography (hexanes/EtOAc /HOAc 70:30:1) furnished	  the desired product (0.290 
g, 0.70 mmol, 90 %) as a white solid. Mp: 116-118 °C; Rf (CH2Cl2/MeOH 9:1) = 0.44; 
1H NMR (CDCl3, 400 MHz):	  δ	  0.81 (t, J = 6.6 Hz, 3H, CH3), 1.16–1.48 (m, 12H, CH2), 
1.61–1.70 (m, 1H, CHHCHO), 1.72–1.80 (m, 1H, CHHCHO), 3.03 (dd, J = 9.2, 10.2 
Hz, 1H, CHCOOH), 3.09–3.15 (m, 1H, CHHSe), 3.32–3.38 (m, 2H, CHHSe and CH-
CH2Se), 4.47 (td, J = 8.8, 4.0 Hz, 1H, CHO), 7.17–7.19 (m, 3H, CH(Ar)), 7.43–7.45 (m, 
2H, CH(Ar)); 13C NMR (CDCl3, 101 MHz)	   δ	  14.2, 22.8, 25.3, 27.1, 29.3, 29.4, 29.5, 
29.8, 31.9, 35.1, 45.5, 51.4, 79.9, 127.8, 129.2, 129.4, 133.1, 174.8, 176.4; IR (KBr): 
2951–2922, 1763, 1697, 1162; HRMS (ESI+) calculated for C20H28NaO4Se [M+Na]+: 
435.1045; found: 435.1039. 
 
Preparation of C75 by oxidation of 3. 
H2O2 30% (48 µL, 0.428 mmol) was added to a stirred solution of 3 (0.044 g, 0.107 
mmol) in THF (0.6 mL) at room temperature. After 2.5 h, the resulting mixture was 
diluted with CH2Cl2 (6 mL) and sat. NaHCO3 (3 mL) was added. The layers were 
separated and the aqueous layer was washed with CH2Cl2 (3×3 mL) and acidified with 6M 
HCl until pH ~ 1. The aqueous layer was extracted with CH2Cl2 (4×3 mL) and the 
combined organic extracts were washed with brine (8 mL) and dried (MgSO4). Solvent 
evaporation gave C75 (0.022 g, 0.087 mmol, 81%) as a white solid. 
 
cis,trans-­‐2-Octyl-5-oxo-4-[(phenylselanyl)methyl]tetrahydrofuran-3-carboxylic acid. 
A solution of 1 (0.124 g, 0.49 mmol) in anh EtOH (2 mL) was added dropwise via cannula 
to a mixture of Ph2Se2 (0.084 g, 0.27 mmol) and NaBH4 (0.018 g, 0.49 mmol) in EtOH (2.5 
mL) under N2 at room temperature. The resulting yellow solution was stirred 3.5 h and was 
acidified with 2M HCl to pH ~ 1. The volatiles were evaporated and the aqueous residue 
was extracted with CH2Cl2 (3x2 mL). The combined organic extracts were washed with 
20% NH4Cl  (2x2 mL), brine (2 x 2 mL) and water (2 mL), dried (MgSO4) and the solvent 
was removed under vacuum. The resulting crude was purified by flash column 
chromatography (hexanes/EtOAc /HOAc 70:30:1) to give 0.166 g of the desired product 
(0.403 mmol, 83%) as a white solid. Mp: 87-88 °C; Rf (hexanes/EtOAc 8:2) = 0.23; 1H 
NMR (400 MHz, CDCl3): δ 0.87 (t, J = 6.9 Hz, 3H, CH3), 1.13–1.69 (m, 14H, CH2), 
3.10–3.18 (m, 1H, CHCOOH), 3.34–3.41 (m, 2H, CH2Se), 3.60 (t, J = 8.6 Hz, 1H, 
CHCH2Se), 4.70 (td, J = 8.6, 4.3 Hz, 1H, CHO), 7.34–7.21 (m, 3H, CH(Ar)), 7.62 – 
7.45 (m, 2H, CH(Ar)); 13C NMR (101 MHz, CDCl3): δ 14.2, 22.8, 25.8, 26.8, 29.3, 29.5, 
31.7, 31.9, 42.8, 49.2, 77.7, 125.5, 127.9, 129.5, 133.2, 174.5, 175.2. IR (KBr): 3198, 
2920, 2853, 1746, 1653, 1407, 1143; HRMS (ESI+) calculated for C20H28NaO4Se 
[M+Na]+: 435.1045; found: 435.1039. 
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